Your task is to predict the verdict of a claim based on the provided question-answer pair evidence. The possible labels are: 'Supported', 'Refuted', 'Not Enough Evidence', 'Conflicting Evidence/Cherrypicking'. Justify your answer using the provided evidence and select the correct label.

Claim: A Madagascan herbal drink called Covid-Organics, is a treatment or a cure, for COVID-19.

Q1: What are the main ingredients of Covid-Organics?
A1: The Covid-Organics is composed of 62% Artemisia and other medicinal plants with antiseptic properties, bronchial thinner used in the composition of traditional remedies for years.
(Google Translate)

Q2: What does World Health Organisation (WHO) say about the use of Artemisia to treat COVID-19?
A2: Medicinal plants such as Artemisia annua are being considered as possible treatments for COVID-19 and should be tested for efficacy and adverse side effects.

Q3: Has any testing of the use of Artemisia been carried out to treat COVID-19?
A3: The Max Planck Institute of Colloids and Interfaces, Potsdam (Germany) will collaborate with ArtemiLife Inc., a US based company and medical researchers in Denmark and Germany to test Artemisia annua plant extract and artemisinin derivatives in laboratory cell studies against the novel coronavirus Sars-CoV-2.

Q4: Have any results been published on the testing?
A4: Research conducted after the claim date:

Can Artemisia herba-alba Be Useful for Managing COVID-19 and Comorbidities? {Molecules 2022, 27(2), 492; https://doi.org/10.3390/molecules27020492
Received: 17 November 2021 / Revised: 10 January 2022 / Accepted: 10 January 2022 / Published: 13 January 2022
(This article belongs to the Special Issue Bioactivities and In Silico Study of Phytochemicals)}

We show that various phytochemicals of Artemisia herba-alba can be useful against COVID-19 (in silico)...there is no sufficient clinical research evidence based on these compounds for the treatment of SARS-CoV-2. Therefore, after the validation of anti-SARS-CoV-2 activity in in vitro and in vivo research models, these potential bioactive phyto-compounds can prove to be an alternative therapeutic option for SARS-CoV-2 treatment. To conclude, this study connects how the ethnic usages of a given medicinal plant coupled with pharmacological activity reports and the in silico screening of its phytochemicals can lead to the better management of COVID-19, which is extremely important for dealing with COVID-19 and its associated comorbidities.

Q5: At the claim date, what published results are available to verify that artemisia can be used successfully to treat COVID-19?
A5: No answer could be found.
user
justification: Evidence finds that the "Covid-Organics" herbal drink is composed of 62% Artemisia. Artemisia has been considered as a possible treatment for COVID-19 and should be tested for efficacy and adverse side effects. Artemisia herba-alba has also been found to be useful against COVID-19 (in silico); however, there is insufficient clinical research evidence based on these compounds for the treatment of SARS-CoV-2.

verdict: 'Conflicting Evidence/Cherrypicking'
assistant